Trafalgar International (GCAN) Shares Outstanding (Entity) (2016 - 2026)
Powered by 
Analysis
Trafalgar International (GCAN) Shares Outstanding (Entity) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 944,935.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 944,935.00 |
| Dec 31, 2025 | 944,935.00 |
| Sep 30, 2025 | 900,256.00 |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 974.89 Mn |
| Dec 31, 2024 | 804.64 Mn |
| Sep 30, 2024 | 804.64 Mn |
| Jun 30, 2024 | 804.64 Mn |
| Mar 31, 2024 | 804.64 Mn |
| Dec 31, 2023 | 804.64 Mn |
| Sep 30, 2023 | 768.64 Mn |
| Jun 30, 2023 | 732.64 Mn |
| Mar 31, 2023 | 732.64 Mn |
| Dec 31, 2022 | 587.77 Mn |
| Sep 30, 2022 | 668.64 Mn |
| Jun 30, 2022 | 533.64 Mn |
| Mar 31, 2022 | 508.64 Mn |
| Dec 31, 2021 | 508.64 Mn |
| Sep 30, 2021 | 508.64 Mn |
| Jun 30, 2021 | 478.64 Mn |